Bulldock Max 25 SC Suspensionskoncentrat Danimarka - Daniż - SEGES Landbrug & Fødevarer

bulldock max 25 sc suspensionskoncentrat

nufarm deutschland gmbh - beta-cyfluthrin - suspensionskoncentrat - 25 g/l beta-cyfluthrin

Orius Max 200 EW Olie i vand emulsion Danimarka - Daniż - SEGES Landbrug & Fødevarer

orius max 200 ew olie i vand emulsion

nufarm deutschland gmbh - tebuconazol - olie i vand emulsion - 200 g/l tebuconazol

Mirador Forte EC Emulsionskoncentrat Danimarka - Daniż - SEGES Landbrug & Fødevarer

mirador forte ec emulsionskoncentrat

adama northern europe b.v. - tebuconazol, azoxystrobin - emulsionskoncentrat - 100 g/l tebuconazol ; 60 g/l azoxystrobin

Glacis Emulsionskoncentrat Danimarka - Daniż - SEGES Landbrug & Fødevarer

glacis emulsionskoncentrat

bayer a/s - prothioconazol - emulsionskoncentrat - 250 g/l prothioconazol

Profound Emulsionskoncentrat Danimarka - Daniż - SEGES Landbrug & Fødevarer

profound emulsionskoncentrat

bayer a/s - prothioconazol - emulsionskoncentrat - 250 g/l prothioconazol

Hormotex 750 Vandopløseligt koncentrat Danimarka - Daniż - SEGES Landbrug & Fødevarer

hormotex 750 vandopløseligt koncentrat

scandiflex nordic a/s - mcpa - vandopløseligt koncentrat - 750 g/l mcpa

SweDane MCPA 750 Flydende middel Danimarka - Daniż - SEGES Landbrug & Fødevarer

swedane mcpa 750 flydende middel

nufarm deutschland gmbh - mcpa - flydende middel - 750 g/l mcpa

Mhyosphere PCV ID Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

mhyosphere pcv id

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - svin - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.